share_log

TD Cowen Initiates Coverage On Jasper Therapeutics With Outperform Rating

Moomoo 24/7 ·  Mar 18 08:34

TD Cowen analyst Yaron Werber initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rating.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment